Become a Sponsor & Connect with TEN Capital Network
Gain visibility, build relationships, and engage with high-net-worth investors through our exclusive Family Office events.
Why Sponsor With TEN Capital Network?
Position your brand in front of ultra-high-net-worth investors & decision-makers.
- Active Angel Investors
- Venture Capital Partners
- Family Office Investment teams
- Startup Founders Raising Seed to Series A
- Advisors Supporting Venture-backed companies
Who Sponsors With Us & Why?
- Position their brand in front of active venture investors and founders
- Showcase tools that support startup fundraising and venture investing
- Participate in investor education programs powered by AI and data analytics
- Engage directly with decision-makers through events, panels, and digital programs
- 25,000+ accredited investors
- Seed to Series A startup deal flow
- Family office and venture capital panels
- Investor newsletters and educational programming
- AI-driven investor insights and venture analytics tools
Who Attends Our Events
Connect with Industry Leaders & Investment Decision-Makers
TEN Capital’s Family Office events bring together a curated mix of high-impact professionals, from accredited investors and venture-backed startups to legal and financial experts and emerging fund managers. Our sponsors gain direct access to a targeted audience actively engaged in the venture investment ecosystem-ensuring meaningful connections and valuable networking opportunities.
AI investment research platforms
Active investors seeking high-growth startups and quality deal flow.
Venture analytics and data providers
Fractional CFOs, investment strategists, and PEO firms supporting growth.
Fund administration and legal services
FDA, compliance, and industry specialists ensuring startup success.
Startup infrastructure providers
Attorneys, patent specialists, and legal experts guiding startups.
Family Offices & Wealth Management
HNWIs, family offices, and institutional investors exploring new opportunities.
Venture SaaS Tools
Venture-backed startups in tech, life sciences, fintech, and AI seeking funding.
Featured Companies
Featured Industries
01
Technology
Fueling the Future of Innovation
The next wave of groundbreaking startups in software, hardware, and emerging technologies.
02
Life Sciences
Health & Biotech Advancements
Cutting-edge medical devices, biotech, and digital healthcare innovations transforming patient care.
03
AI & machine Learning
Shaping the Future with AI-Powered Solutions
Venture into artificial intelligence, deep learning, and automation redefining industries.
04
Fintech & SaaS
Revolutionizing Finance & Digital Solutions
Explore next-gen payments and enterprise SaaS shaping finance.
05
Sustainable | Impact Investing
Funding a Greener, More Sustainable Future
Invest in clean tech, ESG, and startups shaping the future.
Upcoming Investor Events
Network. Discover. Invest.
See Our Upcoming Events Below:
Eventbrite Upcoming Events Embed
Up-Coming Events
TEN Capital Investor Education Series
3/03/2026 1:00 PM CST
Click here to view event details
Master the art of startup investing with expert-led insights and actionable strategies with TEN Capital.
TEN Capital Syndicate 10/10 Session
4/11/2026 3:00 PM CDT
Click here to view event details
Great source of deal flow for all investors.
TEN Capital Syndicate10/10 Session, where healthcare expertise meets breakthrough innovation.
Join us for a fast-paced, high-impact session designed exclusively for investors and healthcare leaders exploring the next wave of Life Science, Medical Device, Digital Health, and Biotech opportunities.
In this special 10/10 format, each presenting startup delivers a focused 10-minute pitch followed by a 10-minute Q&A with our panel of industry experts, giving you a clear, structured look at the solutions shaping the future of healthcare.
TEN Capital clients pitching are Solaris Endovascular, Angiex Inc., and Novuson.
TEN Capital curates ready-to-fund opportunities each month, bringing hand-selected ventures directly to syndicate members. Expect high-quality deal flow, expert insights, and a streamlined process for evaluating emerging companies in the life sciences ecosystem.
This power session is your opportunity to hear directly from founders, gain deeper insight into their technologies, and discover investment opportunities aligned with your interests, all in a time-efficient, investor-focused format.
Don’t miss this special event designed to inform, engage, and elevate your investment strategy in the rapidly evolving world of life science innovation.
Register Now: Wednesday, March 11th at 4 PM ET / 3 PM CT / 1 PM PT
** This is an Investors’ only event. If you are a startup and wish to attend and or have questions about TEN Capita,l we can be reached here **
TEN Capital Pitch & Match
4/18/2026 3:00 PM CDT
Click here to view event details
Great source of deal flow for all investors.
Join TEN Capital Network for our next TEN Capital Quick Pitch Session, a focused and time-efficient investor pitch format designed to maximize engagement and deliver actionable feedback.
This month’s session features TEN Capital clients, including Angiex Inc. and Groupize, showcasing innovative solutions across multiple sectors. We’ll kick off with brief introductions from our CEO, Hall Martin, and the investor panel (insert panel/ investors) before moving into the structured pitch and Q&A segments.
This is an excellent opportunity to gain valuable insights into the world of venture capital and hear directly from founders building high-growth companies.
Register Now: Wednesday, March 11th at 4 PM ET / 3 PM CT / 1 PM PT
**This event is for Investors only. If you are a startup and wish to attend or would like more information about what TEN Capital Network offers, reach out to us here.
TEN Capital x X1: The Investability Pipeline Special Event
4/24/2026 9:00 AM CDT
Click here to view event details
Exclusive investor pitch event with vetted startups, live pitches, and data-driven investability insights for founders and investors.
TEN Capital and X1 Pipeline invite you to an exclusive, live investor pitch event featuring vetted early-stage startups, structured evaluation insights, and direct investor engagement.
Startups invited to pitch have been reviewed using the X1 Pipeline Investability Score, giving investors a structured, objective view of each company’s underlying investment potential. The Investability Score is designed to support decision-making and prioritization, not to replace investor diligence or provide investment advice.
From there, the top 10 high-scoring companies are selected to present live at this event.
Each selected startup delivers a three-minute pitch, followed by a two-minute live investor Q&A, creating a fast-paced, focused session built for clarity and capital efficiency.
This experience brings together founders and active investors for a highly curated, data-supported pitch format designed to streamline review, highlight strengths, and surface high-potential opportunities.
What Makes This Event Different:
- Startups invited to pitch have been reviewed using the X1 Pipeline Investability Score, which provides investors with a structured, objective snapshot of fundraising readiness. The Score is designed to support decision-making and prioritization — not replace investor diligence or provide investment advice.
- In addition, participating startups receive a detailed Investability Report with actionable feedback to help refine their pitch, strengthen investor readiness, and accelerate growth.
Investors benefit from:
- Clear, structured insights into each presenting company
- Faster evaluation of fundraising readiness signals
- A curated selection of high-scoring opportunities
- Direct engagement during live Q&A
What You’ll Learn & Experience:
- How scoring tools can help assess fundraising readiness
- What drives investor interest and key investability signals
- Live three-minute pitches from selected startups
- Two-minute live investor Q&A per company
- How data-driven evaluation supports more efficient deal review
- Direct engagement with investors, funds, accelerators, and ecosystem partners
About the X1 Pipeline Investability Score:
- 11,000+ Startups reviewed in the last 18 months
- A structured, data-driven framework designed to support investor review and founder preparation
- identifies strengths, gaps, and readiness indicators that investors commonly assess
- Who Should Attend
Investor: Join the panel, engage in live Q&A, and review high-scoring opportunities selected through a structured evaluation process.
Founders: Complete your free X1 profile for a chance to be selected as a Top 10 presenter and gain valuable investor-facing insights.
Funds, Accelerators & Ecosystem Partners: Support portfolio companies and discover new opportunities within a curated, high-signal environment.
Interested in seeing where your startup scores and would like to be part of this event?
Click Here
Register Now: Tuesday, March 24th, 9 AM CST – 10:30 AM CST
About X1 Pipeline
X1 Pipeline is an AI-native platform unifying startups, investors, and corporates to streamline discovery, evaluation, and funding. It uses real-time data and proprietary investability scoring to match high-potential startups with investors, offering actionable insights, intelligent deal flow, and a unified innovation ecosystem.
About TEN Capital Network
TEN Capital helps startups, growth companies, and investors raise funding through its extensive fundraising program. Our services include fundraising preparation, campaign strategy and coaching, investor engagement, and introductions, email and digital marketing campaigns, pitch events, webinars, podcast interviews, assistance with investment closing, and more. In short, we provide the legwork, saving you time and money.
TEN Capital regularly organizes online events to connect startups with investors. Contact us today to join the TEN Capital network and participate in a future pitch session as a presenting company or Investor partner.
📢 By registering, attendees agree to receive event updates via email and text, including sponsor offers and partner content. Some events may include real-time feedback requests. Photos and videos may be captured and used for promotional purposes by organizers and attendees.
Solar Endovascular Investor Event: Transforming Dialysis Access
4/30/2026
Click here to view event details
Transforming Dialysis Access: A Breakthrough Approach to AV Access Dysfunction
Join us for a special investor-focused session examining a major unmet need in healthcare: arteriovenous (AV) access failure in hemodialysis patients. Reliable vascular access is essential for survival, yet current treatment options remain reactive, invasive, and prone to frequent failure, driving repeated interventions, poor patient outcomes, and high system-wide costs.
This event will feature leaders from Solaris Endovascular and Echelon Development Group, who will present a comprehensive view of the clinical problem, limitations of existing therapies, and a differentiated, data-driven approach designed to fundamentally change dialysis access repair. Attendees will gain insight into new clinical data supporting a breakthrough FDA designation, the regulatory and clinical rationale behind the technology, and the business case for its development and investment potential.
What You’ll Learn
- The scale and impact of AV access dysfunction in hemodialysis patients
- Why current dialysis access treatments fail to deliver durable outcomes
- How Solaris Endovascular’s technology targets the underlying mechanisms of access failure
- Early clinical data and its implications for regulatory strategy and FDA pathways
- Comparative advantages of Solaris DX versus existing therapies
- The clinical, economic, and investment rationale behind Solaris Endovascular
Who Should Attend
- High-net-worth investors, angel investors, family offices, and small funds
- Investors interested in life sciences, medical devices, and healthcare innovation
- Physicians and clinical leaders involved in dialysis and vascular care
- Ecosystem participants evaluating emerging healthcare technologies
- By the end of this session, attendees will have a clearer understanding of the dialysis access problem, why current solutions fall short, and how Solaris Endovascular’s platform technology represents a potentially transformational opportunity for patients, providers, and investors.
Register Now: Monday, March 30th at 2 PM CT/3 PM ET
Randy Hubbell, CEO – Solaris Endovascular
Randy Hubbell is a seasoned medical technology executive with extensive experience commercializing transformational devices and scaling global healthcare businesses. His leadership background includes senior roles at Johnson & Johnson and Boston Scientific, including serving as Vice President of Worldwide Marketing at Johnson & Johnson.
Randy has also served as Chairman, President, and CEO of Carmell Corporation (NASDAQ: CTCX) and as Chief Commercial Officer at Cardiva Medical, a startup later acquired by Haemonetics. He holds a Bachelor of Science in Computer Science from Tulane University and an MBA from Loyola University of New Orleans.
About Solaris Endovascular
Solaris Endovascular, Inc. is a U.S.-based growth-stage medical device company developing advanced endovascular solutions for dialysis access challenges and peripheral artery disease. With a proven stent platform approved in more than 45 countries and over 15,000 units sold, Solaris is the only company with a drug-eluting covered stent currently in clinical use—positioned to fundamentally change dialysis access and vascular repair.
Dr. Robert E. Lee, Founder – Echelon Development Group
Dr. Robert E. Lee is a board-certified vascular surgeon with more than 30 years of experience across clinical practice, FDA medical device regulation, and medtech strategy. He earned his medical degree from the University of Michigan and completed his surgical training at Henry Ford Hospital in Detroit.
Dr. Lee joined the U.S. Food and Drug Administration in 2015, becoming the first board-certified vascular surgeon to serve as a Medical Officer within the Center for Devices and Radiological Health (CDRH). There, he evaluated vascular and endovascular devices across their full lifecycle, including technologies used to create, maintain, and salvage AV access.
After his federal service, Dr. Lee co-founded Echelon Development Group, where he advises innovators and investors on regulatory, clinical, and market strategy for high-impact vascular technologies, with a focus on renal care and AV access.
About Echelon Development Group
Echelon Development Group is a specialized advisory firm operating at the intersection of vascular medicine, medical device regulation, and capital strategy. The firm helps innovators and investors reduce execution risk and align development decisions with regulatory, clinical, and market realities.
About TEN Capital Network
TEN Capital helps startups, growth companies, and investors raise funding through its extensive fundraising program. Our services include fundraising preparation, campaign strategy and coaching, investor engagement and introductions, email and digital marketing campaigns, pitch events, webinars, podcast interviews, assistance with investment closing, and more. In short, we provide the legwork, saving you time and money.
TEN Capital regularly organizes online events to connect startups with investors. Contact us today to join the TEN Capital network and participate in a future pitch session as a presenting company or Investor partner.
📢 By registering, attendees agree to receive event updates via email and text, including sponsor offers and partner content. Some events may include requests for real-time feedback. Organizers and attendees may capture and use photos and videos for promotional purpose
What is the TEN Sponsorship Partner Vision?
- Expert Curation – Backed by decades of investment expertise.
- Deep Market Insights – AI-driven research and proprietary investor tools.
- Investor-First Approach – Fully aligned with your family office goals.
